Other Viruses Citation List: April 11 - April 24, 2014

Hepatitis B Virus

1. Retinazone Inhibits Certain Blood-borne Human Viruses Including Ebola Virus Zaire. Kesel, A.J., Z. Huang, M.G. Murray, M.N. Prichard, L. Caboni, D.K. Nevin, D. Fayne, D.G. Lloyd, M.A. Detorio, and R.F. Schinazi. Antiviral Chemistry & Chemotherapy, 2014. 23(5): p. 197-215; PMID[23636868].

[PubMed]. OV_0411-042414.

Hepatitis C Virus

2. Inhibitory Effect of Kaolin Minerals Compound against Hepatitis C Virus in Huh-7 Cell Lines. Ali, L., M. Idrees, M. Ali, A. Hussain, I.U. Rehman, A. Ali, S.A. Iqbal, and E.H. Kamel. BMC Research Notes, 2014. 7(1): p. 247; PMID[24742271].

[PubMed]. OV_0411-042414.

3. Identification of a Novel Series of Potent HCV NS5B Site I Inhibitors. Eastman, K.J., Z. Yang, J.A. Bender, K. Mosure, J.A. Lemm, N.A. Meanwell, S.B. Roberts, J. Knipe, and J.F. Kadow. Bioorganic & Medicinal Chemistry Letters, 2014. 24(8): p. 1993-1997; PMID[24656612].

[PubMed]. OV_0411-042414.

4. The Acyclic Retinoid Peretinoin Inhibits Hepatitis C Virus Replication and Infectious Virus Release in Vitro. Shimakami, T., M. Honda, T. Shirasaki, R. Takabatake, F. Liu, K. Murai, T. Shiomoto, M. Funaki, D. Yamane, S. Murakami, S.M. Lemon, and S. Kaneko. Scientific Reports, 2014. 4: p. 4688; PMID[24732793].

[PubMed]. OV_0411-042414.

5. Development of Bivalent Oleanane-type Triterpenes as Potent HCV Entry Inhibitors. Yu, F., Y. Peng, Q. Wang, Y. Shi, L. Si, H. Wang, Y. Zheng, E. Lee, S. Xiao, M. Yu, Y. Li, C. Zhang, H. Tang, C. Wang, L. Zhang, and D. Zhou. European Journal of Medicinal Chemistry, 2014. 77: p. 258-268; PMID[24650713].

[PubMed]. OV_0411-042414.

Herpes Simplex Virus 2

6. A Potent Combination Microbicide That Targets SHIV-RT, HSV-2 and HPV. Kizima, L., A. Rodriguez, J. Kenney, N. Derby, O. Mizenina, R. Menon, S. Seidor, S. Zhang, K. Levendosky, N. Jean-Pierre, P. Pugach, G. Villegas, B.E. Ford, A. Gettie, J. Blanchard, M. Piatak, Jr., J.D. Lifson, G. Paglini, N. Teleshova, T.M. Zydowsky, M. Robbiani, and J.A. Fernandez-Romero. Plos One, 2014. 9(4): p. e94547; PMID[24740100].

[PubMed]. OV_0411-042414.

Citations from the ISI Web of Knowledge Listings for O.V.

7. Potent Hepatitis C Virus NS5A Inhibitors Containing a Benzidine Core. Bae, I.H., J.K. Choi, C. Chough, S.J. Keum, H. Kim, S.K. Jang, and B.M. Kim. ACS Medicinal Chemistry Letters, 2014. 5(3): p. 255-258; ISI[000333006200006].

[WOS]. OV_0411-042414.

8. Discovery of SCH 900188: A Potent Hepatitis C Virus NS5B Polymerase Inhibitor Prodrug as a Development Candidate. Chen, K.X., S. Venkatraman, G.N. Anilkumar, Q.B. Zeng, C.A. Lesburg, B. Vibulbhan, F. Velazquez, T.Y. Chan, F. Bennet, Y.H. Jiang, P. Pinto, Y.H. Huang, O. Selyutin, S. Agrawal, H.C. Huang, C. Li, K.C. Cheng, N.Y. Shih, J.A. Kozlowski, S.B. Rosenblum, and F.G. Njoroge. ACS Medicinal Chemistry Letters, 2014. 5(3): p. 244-248; ISI[000333006200004].

[WOS]. OV_0411-042414.

9. Discovery of Thienoimidazole-based HCV NS5A Genotype 1a and 1b Inhibitors. Giroux, S., J.W. Xu, T.J. Reddy, M. Morris, K.M. Cottrell, C. Cadilhac, J.A. Henderson, O. Nicolas, D. Bilimoria, F. Denis, N. Mani, N. Ewing, R. Shawgo, L. L'Heureux, S. Selliah, L. Chan, N. Chauret, F. Berlioz-Seux, M.N. Namchuk, A.L. Grillot, Y.L. Bennani, S.K. Das, and J.P. Maxwell. ACS Medicinal Chemistry Letters, 2014. 5(3): p. 240-243; ISI[000333006200003].

[WOS]. OV_0411-042414.

10. Novel Peptidomimetic Hepatitis C Virus NS3/4A Protease Inhibitors Spanning the P2-P1 ' Region. Lampa, A.K., S.M. Bergman, S.S. Gustafsson, H. Alogheli, E.B. Akerblom, G.G. Lindeberg, R.M. Svensson, P. Artursson, U.H. Danielson, A. Karlen, and A. Sandstrom. ACS Medicinal Chemistry Letters, 2014. 5(3): p. 249-254; ISI[000333006200005].

[WOS]. OV_0411-042414.

11. Novel Quinoline-based P2-P4 Macrocyclic Derivatives as Pan-genotypic HCV NS3/4A Protease Inhibitors. Shah, U., C. Jayne, S. Chackalamannil, F. Velaazquez, Z.Y. Guo, A. Buevich, J.A. Howe, R. Chase, A. Soriano, S. Agrawal, M.T. Rudd, J.A. McCauley, N.J. Liverton, J. Romano, K. Bush, P.J. Coleman, C. Grise-Bard, M.C. Brochu, S. Charron, V. Aulakh, B. Bachand, P. Beaulieu, H. Zaghdane, S. Bhat, Y.X. Han, J.P. Vacca, I.W. Davies, A.E. Weber, and S. Venkatraman. ACS Medicinal Chemistry Letters, 2014. 5(3): p. 264-269; ISI[000333006200008].

[WOS]. OV_0411-042414.